Back to search

Article

Real-world Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 Patients

2021-03-31

Abstract excerpt

<title>Abstract</title> <p>COVID-19 has spurred much interest in the therapeutic potential of repurposed drugs, such as acid-reducing drugs that act as histamine H2 receptor antagonists (H2RA). These compounds, exemplified by famotidine (e.g., Pepcid) and ranitidine (e.g., Zantac), bind the H2R and block the histamine-triggered stimulation of signal transduction cascades. Histamine and H2RAs, on the one hand, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bb59cdf0-bb4d-54b6-a3fa-c3eb8b8d2e1c
DOI
10.21203/rs.3.rs-369927/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-world Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 PatientsDOI 10.21203/rs.3.rs-369927/v1
Select a neighboring publication to make it the new centre.